BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26412275)

  • 1. Topical antioxidants in radiodermatitis: a clinical review.
    Kodiyan J; Amber KT
    Int J Palliat Nurs; 2015 Sep; 21(9):446-52. PubMed ID: 26412275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antioxidants in radiotherapy-induced skin toxicity.
    Amber KT; Shiman MI; Badiavas EV
    Integr Cancer Ther; 2014 Jan; 13(1):38-45. PubMed ID: 23729466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efectiveness of topical therapies in patients with breast cancer that experience radiodermatitis. A systematic review].
    Fernández-Castro M; Martín-Gil B
    Enferm Clin; 2015; 25(6):327-43. PubMed ID: 26475084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of skin toxicity during radiation therapy: a review of the evidence.
    Kumar S; Juresic E; Barton M; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Jun; 54(3):264-79. PubMed ID: 20598015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal preparation extract for skin after radiotherapy treatment. Part One--Preclinical tests.
    Skalska-Kamińska A; Woźniak A; Paduch R; Kocjan R; Rejdak R
    Acta Pol Pharm; 2014; 71(5):781-8. PubMed ID: 25362806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
    Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
    Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial.
    Karbasforooshan H; Hosseini S; Elyasi S; Fani Pakdel A; Karimi G
    Phytother Res; 2019 Feb; 33(2):379-386. PubMed ID: 30479044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial.
    Wells M; Macmillan M; Raab G; MacBride S; Bell N; MacKinnon K; MacDougall H; Samuel L; Munro A
    Radiother Oncol; 2004 Nov; 73(2):153-62. PubMed ID: 15542162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting evidence into practice.
    Feight D; Baney T; Bruce S; McQuestion M
    Clin J Oncol Nurs; 2011 Oct; 15(5):481-92. PubMed ID: 21951735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol Paper: A Randomized Trial of 2 Creams in the Skin Care of Patients Receiving Radiation Therapy for Breast Cancer in the Tropics.
    Heyer E; Smyth W; Laffin N; Gardner A
    Cancer Nurs; 2015; 38(4):E35-41. PubMed ID: 25075645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of topical agents on radiation-induced skin disease by reflectance spectrophotometry.
    Rizza L; D'Agostino A; Girlando A; Puglia C
    J Pharm Pharmacol; 2010 Jun; 62(6):779-85. PubMed ID: 20636866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced skin alterations.
    Blackmar A
    Medsurg Nurs; 1997 Jun; 6(3):172-5. PubMed ID: 9238995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of acute radiation dermatitis: a literature review.
    Wickline MM
    Oncol Nurs Forum; 2004; 31(2):237-47. PubMed ID: 15017440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of radiation skin reactions: literature review and clinical application.
    Porock D; Nikoletti S; Kristjanson L
    Plast Surg Nurs; 1999; 19(4):185-92, 223; quiz 191-2. PubMed ID: 12024597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Application of Phlorotannins from Brown Seaweed Mitigates Radiation Dermatitis in a Mouse Model.
    Yang K; Kim SY; Park JH; Ahn WG; Jung SH; Oh D; Park HC; Choi C
    Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32707897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions--results from a randomised blinded trial.
    Sharp L; Finnilä K; Johansson H; Abrahamsson M; Hatschek T; Bergenmar M
    Eur J Oncol Nurs; 2013 Aug; 17(4):429-35. PubMed ID: 23245940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
    Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
    Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiodermatitis: A Review of Our Current Understanding.
    Singh M; Alavi A; Wong R; Akita S
    Am J Clin Dermatol; 2016 Jun; 17(3):277-92. PubMed ID: 27021652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of an amorphous dressing in the skin care of patients after radiotherapy].
    Añón Vera JL; Llopis Puigmartí F; León Amo R; Grisó Jurado B; Esteban Jiménez C; López Grau J; Vidal Villacampa E; Anglada Tort L; Borras Balada JL
    Rev Enferm; 1998 Nov; 21(243):55-60. PubMed ID: 10026612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superoxidase dismutase (SOD) topical use in oncologic patients: treatment of acute cutaneous toxicity secondary to radiotherapy.
    Manzanas García A; López Carrizosa MC; Vallejo Ocaña C; Samper Ots P; Delgado Pérez JM; Carretero Accame E; Gómez-Serranillos P; de la Morena del Valle L
    Clin Transl Oncol; 2008 Mar; 10(3):163-7. PubMed ID: 18321819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.